• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辉瑞-BioNTech 新冠疫苗在意大利北部伦巴第大区米兰医护人员中的免疫原性和有效性。

Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy).

机构信息

Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan (Italy);

These authors equally contributed to this paper.

出版信息

Epidemiol Prev. 2022 Jul-Aug;46(4):250-258. doi: 10.19191/EP22.4.A513.065.

DOI:10.19191/EP22.4.A513.065
PMID:36259341
Abstract

OBJECTIVES

to evaluate immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers (HCWs).

DESIGN

cohort study.

SETTING AND PARTICIPANTS

in a hospital in Milan (Lombardy Region, Northern Italy) HCWs without ("negative cohort") and with ("positive cohort") history of SARS-CoV-2 infection or elevated serum antibody before the vaccination campaign (27.12.2020) were included. Data collection and follow-up covered the period 27.12.2020-13.05.2022.

MAIN OUTCOMES MEASURES

  1. serum anti-spike-1 (anti-S1) antibody levels after vaccination; 2. vaccine effectiveness (VE) against SARS-CoV-2 infections (either symptomatic or not) in the negative cohort. Data on infections were extracted from multiple sources (laboratory, accident reports, questionnaires). Vaccination was treated as a time-dependent variable. Using unvaccinated person-time as reference, hazard ratios (HR) of infections and 95% confidence intervals (95%CI) were calculated with a Cox regression model adjusted for gender, age, and occupation. VE was calculated as (1 - HR)×100.

RESULTS

5,596 HCWs were included, 4,771 in the negative and 825 in the positive cohort. In both cohorts, serum anti-S1 antibodies were high one months after the second dose, halved after six months, and returned to high levels after the third dose. In the negative cohort, 1,401 SARS-CoV-2 infections were identified. VE was 70% (95%CI 54-80; 46 infected) in the first four months after the second dose and later declined to 16% (95%CI 0-43; 97 infected). After the third dose, VE increased to 57% (95%CI 35-71; 61 infected) in the first month but rapidly declined over time, particularly after three months (24% in the fourth month and 1% afterwards). The number of infections avoided by vaccination was estimated to be 643 (95%CI 236-1,237).

CONCLUSIONS

in spite of rapidly declining effectiveness, vaccination helped to avoid several hundred infections in the considered hospital.

摘要

目的

评估 BNT162b2 COVID-19 疫苗在医护人员(HCWs)队列中的免疫原性和有效性。

设计

队列研究。

地点和参与者

在米兰的一家医院(意大利北部伦巴第大区),纳入了在疫苗接种运动前(2020 年 12 月 27 日)没有(“阴性队列”)和有(“阳性队列”)SARS-CoV-2 感染史或血清抗体升高的 HCWs。数据收集和随访覆盖了 2020 年 12 月 27 日至 2022 年 5 月 13 日的时间段。

主要结局指标

  1. 接种疫苗后血清抗刺突蛋白-1(抗-S1)抗体水平;2. 阴性队列中针对 SARS-CoV-2 感染(无论症状或无症状)的疫苗有效性(VE)。感染数据来自多个来源(实验室、事故报告、问卷调查)。将疫苗接种作为时间依赖性变量。使用未接种人员的时间作为参考,使用 Cox 回归模型调整性别、年龄和职业,计算感染的风险比(HR)和 95%置信区间(95%CI)。VE 计算为(1 - HR)×100。

结果

共纳入 5596 名 HCWs,其中 4771 名在阴性队列,825 名在阳性队列。在两个队列中,第二次接种后一个月血清抗-S1 抗体水平较高,六个月后减半,第三次接种后又恢复到高水平。在阴性队列中,共发现 1401 例 SARS-CoV-2 感染。第二次接种后四个月 VE 为 70%(95%CI 54-80;46 例感染),随后下降至 16%(95%CI 0-43;97 例感染)。第三次接种后,第一个月 VE 增加至 57%(95%CI 35-71;61 例感染),但随着时间的推移迅速下降,尤其是在三个月后(第四个月 24%,之后为 1%)。估计接种疫苗可避免 643 例(95%CI 236-1237)感染。

结论

尽管有效性迅速下降,但疫苗接种仍有助于避免该医院发生数百例感染。

相似文献

1
Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy).辉瑞-BioNTech 新冠疫苗在意大利北部伦巴第大区米兰医护人员中的免疫原性和有效性。
Epidemiol Prev. 2022 Jul-Aug;46(4):250-258. doi: 10.19191/EP22.4.A513.065.
2
Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.BNT162b2 mRNA 冠状病毒病 2019(COVID-19)疫苗在长期护理机构医护人员中预防严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)获得性感染的有效性:一项前瞻性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e755-e763. doi: 10.1093/cid/ciab918.
3
Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March-December 2021.2021 年 3 月至 12 月期间,格鲁吉亚医护人员的 COVID-19 疫苗初级系列接种有效性。
PLoS One. 2024 Sep 6;19(9):e0307805. doi: 10.1371/journal.pone.0307805. eCollection 2024.
4
COVID-19 Immunity in the Cohort of IRCCS San Raffaele Hospital Employees after BNT162b2 Vaccination: A Retrospective Observational Study.辉瑞-BioNTech 疫苗接种后意大利圣拉斐尔医院员工队列的 COVID-19 免疫:一项回顾性观察研究。
Ann Ig. 2024 Jul-Aug;36(4):432-445. doi: 10.7416/ai.2024.2615. Epub 2024 Feb 22.
5
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.2021 年 12 月 1 日至 2022 年 5 月 31 日,在意大利东北部的的里雅斯特和戈里齐亚的医护人员中,奥密克戎传播期间的 SARS-CoV-2 初次感染、再感染和疫苗有效性。
Viruses. 2022 Nov 30;14(12):2688. doi: 10.3390/v14122688.
6
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.BNT162b2 疫苗接种与医护人员中出现有症状和无症状 SARS-CoV-2 感染的相关性。
JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152.
7
Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列医护人员接种第四剂 BNT162b 疫苗与 SARS-CoV-2 感染的关联。
JAMA Netw Open. 2022 Aug 1;5(8):e2224657. doi: 10.1001/jamanetworkopen.2022.24657.
8
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列卫生保健工作者中,第三剂 BNT162b2 疫苗接种与 SARS-CoV-2 感染发生率的关联。
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.
9
Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).的里雅斯特教学医院(意大利东北部)医护人员中新冠病毒疫苗突破性感染的风险及相关因素
Viruses. 2022 Feb 7;14(2):336. doi: 10.3390/v14020336.
10
COVID-19 vaccine effectiveness among healthcare workers: a hospital-based cohort study.COVID-19 疫苗在医护人员中的有效性:一项基于医院的队列研究。
BMJ Open. 2023 May 2;13(5):e068996. doi: 10.1136/bmjopen-2022-068996.

引用本文的文献

1
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review.接种疫苗的医护人员体内抗SARS-CoV-2抗体滴度的动态变化:一项系统文献综述
Vaccines (Basel). 2024 Dec 16;12(12):1419. doi: 10.3390/vaccines12121419.
2
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review.新冠病毒疫苗对医护人员预防有症状感染和严重感染有效:一项临床综述。
Vaccine X. 2024 Aug 5;20:100546. doi: 10.1016/j.jvacx.2024.100546. eCollection 2024 Oct.
3
Vaccination Open Day: A Cross-Sectional Study on the 2023 Experience in Lombardy Region, Italy.
接种开放日:意大利伦巴第大区 2023 年的横断面研究。
Int J Environ Res Public Health. 2024 May 27;21(6):685. doi: 10.3390/ijerph21060685.
4
The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?新冠疫苗第三剂的有效性:何时应接种?
Vaccines (Basel). 2024 Mar 16;12(3):315. doi: 10.3390/vaccines12030315.
5
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022.COVID-19 疫苗对成年人感染、住院和死亡的长期有效性:截至 2022 年 12 月快速实时系统证据综合和荟萃分析的结果。
Lancet Respir Med. 2023 May;11(5):439-452. doi: 10.1016/S2213-2600(23)00015-2. Epub 2023 Feb 10.
6
COVID-19 as an Occupational Disease-Temporal Trends in the Number and Severity of Claims in Germany.COVID-19 作为一种职业病——德国索赔数量和严重程度的时间趋势。
Int J Environ Res Public Health. 2023 Jan 9;20(2):1182. doi: 10.3390/ijerph20021182.